摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2'-Deoxy-3-methyl-3,4-dihydrocytidine | 5040-21-1

中文名称
——
中文别名
——
英文名称
2'-Deoxy-3-methyl-3,4-dihydrocytidine
英文别名
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-methyl-4H-pyrimidin-2-one
2'-Deoxy-3-methyl-3,4-dihydrocytidine化学式
CAS
5040-21-1
化学式
C10H17N3O4
mdl
——
分子量
243.26
InChiKey
LVMJWUXGGRMAIW-QRDCSKFFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    429.4±55.0 °C(Predicted)
  • 密度:
    1.58±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    99.3
  • 氢给体数:
    3
  • 氢受体数:
    5

文献信息

  • [EN] ANTI-CANCER AGENTS<br/>[FR] AGENTS ANTI-CANCEREUX
    申请人:ISIS INNOVATION
    公开号:WO2004058252A2
    公开(公告)日:2004-07-15
    A pharmaceutical combination which comprises: (a) a compound of one of the formulae: formula (I) wherein each of RI and RII, which max be the same or different, represents hydrogen, fluorine or alkyl of 1 to 6 carbon atoms, X represents CRIRII, NRIII or O wherein RIII is hydrogen or alkyl of 1 to 6 carbon atoms, each of Y and Z, which may be the same or different, represents hydrogen, NRIII, OH or SH, or Y and Z together represents =O or =S, or formula (II) where R1 to R11 may independently be H, a branched or straight C1 to C6 alkyl chain, OH, O-alkyl having a branched or straight C1 to C6 alkyl chain optionally containing 1 or 2 N, O or S atoms, COOH, a branched or straight C1 to C6 alkyl ester (alkoxycarbonyl), a 4 to 7 membered heterocyclic ring optionally containing 1 or 2 N, S, O or P atoms or a 5 or 6 membered aromatic ring, optionally containing 1 or more N, O or S atoms, which can be fused to another ring, or a said alkyl chain substituted by a said aromatic ring, and formula (A) represents formula (B) or formula (C) or a pharmaceutically acceptable salt of a said compound; and (b) an anti-cancer alkylating agent. This combination is useful in the treatment of cancer.
查看更多